Middle East & Africa Newborn Screening Market Forecast to 2030
Middle East & Africa Newborn Screening Market Forecast to 2030 – Regional Analysis – by Product Type (Reagents and Assay Kits, and Instruments), Technology [Tandem Mass Spectrometry (TMS), Molecular Assays, Immunoassays and Enzymatic Assays, Pulse Oximetry Screening Technology, and Others], Test Type [Dry Blood Spot Test, Hearing Screen Test, Critical Congenital Heart Diseases (CCHD) Test, and Others], and End User (Hospitals and Clinics, and Diagnostic Laboratories)
$2,485 – $3,885
- Description
- Toplines
- Reasons for Buying
- Table of Contents
- List of Tables
- LIst of Figures
- List of Companies
- Reviews (0)
Description
Integration of Machine Learning and Artificial Intelligence in Screening Fuels the Middle East & Africa Newborn Screening Market
According to a study published in The Lancet Digital Health in April 2023, a new deep-learning artificial intelligence model can help screen newborns for the retinopathy of prematureness. With the increasing availability of genetic and clinical data, machine learning algorithms have the potential to improve the accuracy and efficiency of screening processes. These algorithms can analyze vast datasets, identifying subtle patterns and associations that traditional methods may miss. By integrating machine learning into newborn screening, healthcare providers can improve the early detection of genetic disorders, leading to more timely interventions and better outcomes for infants.
As machine learning models evolve and adapt, they can contribute to the ongoing refinement and personalization of newborn screening protocols. This innovation not only benefits the health of newborns but also presents a significant growth opportunity for companies working on solutions that intersect healthcare and artificial intelligence. Additionally, machine learning can further enhance newborn screening programs by decreasing the false positive rate, raising specificity and positive predictive value, and spotting previously unidentified metabolic patterns in data. Thus, artificial intelligence and machine learning-based newborn screening are poised to become a prominent future trend in the newborn screening market.
Middle East & Africa Newborn Screening Market Overview
The newborn screening market in the Middle East & Africa is segmented into the UAE, Saudi Arabia, South Africa, and the Rest of the Middle East & Africa. Countries such as Saudi Arabia, Qatar, and Lebanon have become regional and international pioneers in newborn screening applications, implementing tandem mass spectrometry (the Kingdom of Saudi Arabia), homocystinuria and TREC-KREK screening (Qatar), G6PD screening (Lebanon), and other advanced testing techniques. In Saudi Arabia, the newborn hearing screening (NHS) program was officially initiated in 2016 across some hospitals; in total, the program was adopted by 147 hospitals as of 2021. According to a study titled “Loss to follow-up in a newborn hearing screening program in Saudi Arabia,” published in September 2023, included all newborns delivered at a tertiary hospital-based NHS program between June 2020 and February 2022. ~2,312 newborns (indicating 96% of the delivered newborns) were screened. The neonatal screening programs in the country are responsible for screening and diagnosing certain disorders to ensure the long-term management of infants’ health. The expanded newborn screening for early treatment and diagnosis of the concerned disease and disorder helps prevent serious health consequences in infants. Newborn screening programs in Saudi Arabia are well-coordinated and comprehensive systems, encompassing screening, diagnosis, treatment, management, and follow-ups.
Birth defects are a major concern as they can result in permanent disability and death in infants. According to the study “Prevalence and Pattern of Birth Defects in Saudi Arabia: A Systematic Review of Observational Studies,” published in July 2023, birth defects remain the leading cause of death among children in Saudi Arabia, and the prevalence of these defects in the country ranged from 8.6/1,000 to 46.45/1,000. As per data by Cortex Digital Marketing LLC, ~970 children are born every year with congenital heart disease in the UAE, which is the leading cause of infant mortality associated with birth defects.
Middle East & Africa Newborn Screening Market Revenue and Forecast to 2030 (US$ Million)
Middle East & Africa Newborn Screening Market Segmentation
The Middle East & Africa newborn screening market is segmented based on product type, technology, test type, end user, and country.
Based on product type, the Middle East & Africa newborn screening market is bifurcated into reagents and assay kits, and instruments. The reagents and assay kits segment held a larger Middle East & Africa newborn screening market share in 2022. The reagents and assay kits segment is subsegmented into DNA-based assays, and immunoassays and enzymatic assays. Instruments segment is subsegmented into newborn disorder screening instruments, pulse oximeters, newborn hearing screening instruments, and other instruments.
In terms of technology, the Middle East & Africa newborn screening market is categorized into tandem mass spectrometry (TMS), molecular assays, immunoassays and enzymatic assay, pulse oximetry screening technology, and other technologies. The pulse oximetry screening technology segment held the largest Middle East & Africa newborn screening market share in 2022.
Based on test type, the Middle East & Africa newborn screening market is categorized into dry blood spot test, hearing screen test, critical congenital heart diseases (CCHD) test, and other test types. The dry blood spot test segment held the largest Middle East & Africa newborn screening market share in 2022.
By end user, the Middle East & Africa newborn screening market is segmented into hospitals and clinics and diagnostic laboratories. The hospitals and clinics segment held a larger Middle East & Africa newborn screening market share in 2022.
Based on country, the Middle East & Africa newborn screening market is categorized into Saudi Arabia, the UAE, South Africa, and the Rest of Middle East & Africa. Saudi Arabia dominated the Middle East & Africa newborn screening market in 2022.
Bio-Rad Laboratories Inc, Masimo Corp, Medtronic Plc, PerkinElmer Inc, and Waters Corp are some of the leading companies operating in the Middle East & Africa newborn screening market.
Summary Info
| Industry: | |
|---|---|
| Pricing options: | |
| Publishing status: | |
| Geographical coverage: | |
| Year of Publication: |
According to The Research Team’ research, the Middle East & Africa newborn screening market was valued at US$ 28.94 in 2022 and is expected to reach US$ 45.24 million by 2030, registering a CAGR of 5.7% from 2022 to 2030. Surging government funding for newborn screening and rising burden of congenital diseases are among the critical factors attributed to the Middle East & Africa newborn screening market expansion.
Governments of different countries are increasingly allocating funds for newborn screening programs. These programs help reduce long-term healthcare costs for children and their parents as congenital and genetic disorders could result in severe health complications and extensive medical interventions if left undetected. By identifying and addressing health issues in infancy, governments can enhance the health and well-being of their citizens. Thus, newborn screening aligns with broader public health objectives to improve overall population health and reduce the burden on healthcare systems.
Government funding promotes equity in healthcare access, ensuring that newborn screening services are available to all, regardless of socioeconomic status. This inclusivity is essential for early disease detection and intervention, as it prevents disparities in healthcare outcomes among different demographic groups. As governments continue to prioritize newborn screening through increased funding and policy support, the newborn screening market has been experiencing sustainable growth worldwide.
On the contrary, lack of uniformity in newborn screening policies and practices hampers the growth Middle East & Africa newborn screening market.
Based on product type, the Middle East & Africa newborn screening market is bifurcated into reagents and assay kits, and instruments. The reagents and assay kits segment held 71.9% share of the Middle East & Africa newborn screening market in 2022, amassing US$ 20.80 million. It is projected to garner US$ 34.64 million by 2030 to expand at 6.6% CAGR during 2022-2030. The reagents and assay kits segment is subsegmented into DNA-based assays, and immunoassays and enzymatic assays. Instruments segment is subsegmented into newborn disorder screening instruments, pulse oximeters, newborn hearing screening instruments, and other instruments.
In terms of technology, the Middle East & Africa newborn screening market is categorized into tandem mass spectrometry (TMS), molecular assays, immunoassays and enzymatic assay, pulse oximetry screening technology, and other technologies. The pulse oximetry screening technology segment held 32.7% share of the Middle East & Africa newborn screening market in 2022, amassing US$ 9.46 million. It is projected to garner US$ 15.35 million by 2030 to expand at 6.2% CAGR during 2022-2030.
Based on test type, the Middle East & Africa newborn screening market is categorized into dry blood spot test, hearing screen test, critical congenital heart diseases (CCHD) test, and other test types. The dry blood spot test segment held 51.9% share of Middle East & Africa newborn screening market in 2022, amassing US$ 15.04 million. It is projected to garner US$ 24.58 million by 2030 to expand at 6.3% CAGR during 2022-2030.
By end user, the Middle East & Africa newborn screening market is segmented into hospitals and clinics and diagnostic laboratories. The hospitals and clinics segment held 64.3% share of Middle East & Africa newborn screening market in 2022, amassing US$ 18.62 million. It is projected to garner US$ 30.92 million by 2030 to expand at 6.5% CAGR during 2022-2030.
Based on country, the Middle East & Africa newborn screening market is categorized into the UAE, South Africa, Saudi Arabia, and the Rest of Middle East & Africa. Saudi Arabia held 45.2% share of Middle East & Africa newborn screening market in 2022, amassing US$ 13.08 million. It is projected to garner US$ 21.64 million by 2030 to expand at 6.5% CAGR during 2022-2030.
Key players operating in the Middle East & Africa newborn screening market are Bio-Rad Laboratories Inc, Masimo Corp, Medtronic Plc, PerkinElmer Inc, and Waters Corp, among others.
– In May 2023, Masimo launched Stork, a revolutionary home baby monitoring system. This innovative system offers parents insights into their baby’s health data, helping them learn more about and connect better with their baby. The Masimo Stork baby monitor system comprises several components and is available in multiple configurations. Masimo Stork Vitals+, the flagship solution, consists of a boot with a sensor, video camera, and mobile app.
o Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Middle East & Africa newborn screening market.
o Highlights key business priorities in order to assist companies to realign their business strategies
o The key findings and recommendations highlight crucial progressive industry trends in the Middle East & Africa newborn screening market, thereby allowing players across the value chain to develop effective long-term strategies
o Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
o Scrutinize in-depth Middle East & Africa market trends and outlook coupled with the factors driving the newborn screening market, as well as those hindering it
o Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution
TABLE OF CONTENTS
1. Introduction
1.1 The Research Team Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Middle East & Africa Newborn Screening Market – Key Industry Dynamics
4.1 Key Market Drivers
4.1.1 Surging Government Funding for Newborn Screening
4.1.2 Rising Burden of Congenital Diseases
4.1.3 Increasing Prevalence of Newborn Disorders
4.2 Key Market Restraints
4.2.1 Lack of Uniformity in Newborn Screening Policies and Practices
4.3 Key Market Opportunities
4.3.1 Genetic Screening of Newborns
4.4 Future Trends
4.4.1 Integration of Machine Learning and Artificial Intelligence in Screening
4.5 Impact Analysis:
5. Newborn Screening Market – Middle East & Africa Market Analysis
5.1 Middle East & Africa Newborn Screening Market Revenue (US$ Mn), 2022 – 2030
6. Middle East & Africa Newborn Screening Market – Revenue and Forecast to 2030 – by Product Type
6.1 Overview
6.2 Middle East & Africa Newborn Screening Market Revenue Share, by Product Type, 2022 & 2030 (%)
6.3 Reagents and Assay Kits
6.3.1 Overview
6.3.2 Reagents and Assay Kits: Middle East & Africa Newborn Screening Market – Revenue and Forecast to 2030 (US$ Million)
6.3.2.1 Middle East & Africa Newborn Screening Market, by Reagents and Assay Kits, 2020-2030 (US$ Million)
6.4 Instruments
6.4.1 Overview
6.4.2 Instruments: Middle East & Africa Newborn Screening Market – Revenue and Forecast to 2030 (US$ Million)
6.4.2.1 Middle East & Africa Newborn Screening Market, by Instruments, 2020-2030 (US$ Million)
7. Middle East & Africa Newborn Screening Market – Revenue and Forecast to 2030 – by Technology
7.1 Overview
7.2 Middle East & Africa Newborn Screening Market Revenue Share, by Technology 2022 & 2030 (%)
7.3 Tandem Mass Spectrometry (TMS)
7.3.1 Overview
7.3.2 Tandem Mass Spectrometry (TMS): Middle East & Africa Newborn Screening Market – Revenue and Forecast to 2030 (US$ Million)
7.4 Molecular Assays
7.4.1 Overview
7.4.2 Molecular Assays: Middle East & Africa Newborn Screening Market – Revenue and Forecast to 2030 (US$ Million)
7.5 Immunoassays and Enzymatic Assays
7.5.1 Overview
7.5.2 Immunoassays and Enzymatic Assays: Middle East & Africa Newborn Screening Market – Revenue and Forecast to 2030 (US$ Million)
7.6 Pulse Oximetry Screening Technology
7.6.1 Overview
7.6.2 Pulse Oximetry Screening Technology: Middle East & Africa Newborn Screening Market – Revenue and Forecast to 2030 (US$ Million)
7.7 Other Technologies
7.7.1 Overview
7.7.2 Other Technologies: Middle East & Africa Newborn Screening Market – Revenue and Forecast to 2030 (US$ Million)
8. Middle East & Africa Newborn Screening Market – Revenue and Forecast to 2030 – by Test Type
8.1 Overview
8.2 Middle East & Africa Newborn Screening Market Revenue Share, by Test Type 2022 & 2030 (%)
8.3 Dry Blood Spot Test
8.3.1 Overview
8.3.2 Dry Blood Spot Test: Middle East & Africa Newborn Screening Market – Revenue and Forecast to 2030 (US$ Million)
8.4 Hearing Screen Test
8.4.1 Overview
8.4.2 Hearing Screen Test: Middle East & Africa Newborn Screening Market – Revenue and Forecast to 2030 (US$ Million)
8.5 Critical Congenital Heart Diseases (CCHD) Test
8.5.1 Overview
8.5.2 Critical Congenital Heart Diseases (CCHD) Test: Middle East & Africa Newborn Screening Market – Revenue and Forecast to 2030 (US$ Million)
8.6 Other Test Types
8.6.1 Overview
8.6.2 Other Test Types: Middle East & Africa Newborn Screening Market – Revenue and Forecast to 2030 (US$ Million)
9. Middle East & Africa Newborn Screening Market – Revenue and Forecast to 2030 – by End User
9.1 Overview
9.2 Middle East & Africa Newborn Screening Market Revenue Share, by End User, 2022 & 2030 (%)
9.3 Hospitals and Clinics
9.3.1 Overview
9.3.2 Hospitals and Clinics: Middle East & Africa Newborn Screening Market – Revenue and Forecast to 2030 (US$ Million)
9.4 Diagnostic Laboratories
9.4.1 Overview
9.4.2 Diagnostic Laboratories: Middle East & Africa Newborn Screening Market – Revenue and Forecast to 2030 (US$ Million)
10. Middle East & Africa Newborn Screening Market – Country Analysis
10.1 Middle East & Africa Newborn Screening Market, Revenue and Forecast to 2030
10.1.1 Middle East & Africa Newborn Screening Market, by Country
10.1.1.1 Saudi Arabia
10.1.1.1.1 Saudi Arabia Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
10.1.1.1.2 Saudi Arabia: Newborn Screening Market, by Product Type, 2020-2030 (US$ Million)
10.1.1.1.2.1 Saudi Arabia: Newborn Screening Market, For Reagents and Assay Kits by Product Type, 2020-2030 (US$ Million)
10.1.1.1.2.2 Saudi Arabia: Newborn Screening Market, For Instruments by Product Type, 2020-2030 (US$ Million)
10.1.1.1.3 Saudi Arabia: Newborn Screening Market, by Technology, 2020-2030 (US$ Million)
10.1.1.1.4 Saudi Arabia: Newborn Screening Market, by Test Type, 2020-2030 (US$ Million)
10.1.1.1.5 Saudi Arabia: Newborn Screening Market, by End User, 2020-2030 (US$ Million)
10.1.1.2 UAE
10.1.1.2.1 UAE Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
10.1.1.2.2 UAE: Newborn Screening Market, by Product Type, 2020-2030 (US$ Million)
10.1.1.2.2.1 UAE: Newborn Screening Market, For Reagents and Assay Kits by Product Type, 2020-2030 (US$ Million)
10.1.1.2.2.2 UAE: Newborn Screening Market, For Instruments by Product Type, 2020-2030 (US$ Million)
10.1.1.2.3 UAE: Newborn Screening Market, by Technology, 2020-2030 (US$ Million)
10.1.1.2.4 UAE: Newborn Screening Market, by Test Type, 2020-2030 (US$ Million)
10.1.1.2.5 UAE: Newborn Screening Market, by End User, 2020-2030 (US$ Million)
10.1.1.3 South Africa
10.1.1.3.1 South Africa Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
10.1.1.3.2 South Africa: Newborn Screening Market, by Product Type, 2020-2030 (US$ Million)
10.1.1.3.2.1 South Africa: Newborn Screening Market, For Reagents and Assay Kits by Product Type, 2020-2030 (US$ Million)
10.1.1.3.2.2 South Africa: Newborn Screening Market, For Instruments by Product Type, 2020-2030 (US$ Million)
10.1.1.3.3 South Africa: Newborn Screening Market, by Technology, 2020-2030 (US$ Million)
10.1.1.3.4 South Africa: Newborn Screening Market, by Test Type, 2020-2030 (US$ Million)
10.1.1.3.5 South Africa: Newborn Screening Market, by End User, 2020-2030 (US$ Million)
10.1.1.4 Rest of Middle East & Africa
10.1.1.4.1 Rest of Middle East & Africa Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
10.1.1.4.2 Rest of Middle East & Africa: Newborn Screening Market, by Product Type, 2020-2030 (US$ Million)
10.1.1.4.2.1 Rest of Middle East & Africa: Newborn Screening Market, For Reagents and Assay Kits by Product Type, 2020-2030 (US$ Million)
10.1.1.4.2.2 Rest of Middle East & Africa: Newborn Screening Market, For Instruments by Product Type, 2020-2030 (US$ Million)
10.1.1.4.3 Rest of Middle East & Africa: Newborn Screening Market, by Technology, 2020-2030 (US$ Million)
10.1.1.4.4 Rest of Middle East & Africa: Newborn Screening Market, by Test Type, 2020-2030 (US$ Million)
10.1.1.4.5 Rest of Middle East & Africa: Newborn Screening Market, by End User, 2020-2030 (US$ Million)
11. Middle East & Africa Newborn Screening Market-Industry Landscape
11.1 Overview
11.2 Growth Strategies in Newborn Screening Market
11.3 Organic Growth Strategies
11.3.1 Overview
11.4 Inorganic Growth Strategies
11.4.1 Overview
12. Company Profiles
12.1 PerkinElmer Inc
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Waters Corp
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Bio-Rad Laboratories Inc
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Masimo Corp
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Medtronic Plc
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
13. Appendix
13.1 About Us
13.2 Glossary of Terms
LIST OF TABLES
Table 1. Middle East & Africa Newborn Screening Market Segmentation
Table 2. Middle East & Africa Newborn Screening Market, by Reagents and Assay Kits – Revenue and Forecast to 2030 (US$ Million)
Table 3. Middle East & Africa Newborn Screening Market, by Instruments – Revenue and Forecast to 2030 (US$ Million)
Table 4. Saudi Arabia Newborn Screening Market, by Product Type – Revenue and Forecast to 2030 (US$ Million)
Table 5. Saudi Arabia Newborn Screening Market, For Reagents and Assay Kits by Product Type – Revenue and Forecast to 2030 (US$ Million)
Table 6. Saudi Arabia Newborn Screening Market, For Instruments by Product Type – Revenue and Forecast to 2030 (US$ Million)
Table 7. Saudi Arabia Newborn Screening Market, by Technology – Revenue and Forecast to 2030 (US$ Million)
Table 8. Saudi Arabia Newborn Screening Market, by Test Type – Revenue and Forecast to 2030 (US$ Million)
Table 9. Saudi Arabia Newborn Screening Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 10. UAE Newborn Screening Market, by Product Type – Revenue and Forecast to 2030 (US$ Million)
Table 11. UAE Newborn Screening Market, For Reagents and Assay Kits by Product Type – Revenue and Forecast to 2030 (US$ Million)
Table 12. UAE Newborn Screening Market, For Instruments by Product Type – Revenue and Forecast to 2030 (US$ Million)
Table 13. UAE Newborn Screening Market, by Technology – Revenue and Forecast to 2030 (US$ Million)
Table 14. UAE Newborn Screening Market, by Test Type – Revenue and Forecast to 2030 (US$ Million)
Table 15. UAE Newborn Screening Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 16. South Africa Newborn Screening Market, by Product Type – Revenue and Forecast to 2030 (US$ Million)
Table 17. South Africa Newborn Screening Market, For Reagents and Assay Kits by Product Type – Revenue and Forecast to 2030 (US$ Million)
Table 18. South Africa Newborn Screening Market, For Instruments by Product Type – Revenue and Forecast to 2030 (US$ Million)
Table 19. South Africa Newborn Screening Market, by Technology – Revenue and Forecast to 2030 (US$ Million)
Table 20. South Africa Newborn Screening Market, by Test Type – Revenue and Forecast to 2030 (US$ Million)
Table 21. South Africa Newborn Screening Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 22. Rest of Middle East & Africa Newborn Screening Market, by Product Type – Revenue and Forecast to 2030 (US$ Million)
Table 23. Rest of Middle East & Africa Newborn Screening Market, For Reagents and Assay Kits by Product Type – Revenue and Forecast to 2030 (US$ Million)
Table 24. Rest of Middle East & Africa Newborn Screening Market, For Instruments by Product Type – Revenue and Forecast to 2030 (US$ Million)
Table 25. Rest of Middle East & Africa Newborn Screening Market, by Technology – Revenue and Forecast to 2030 (US$ Million)
Table 26. Rest of Middle East & Africa Newborn Screening Market, by Test Type – Revenue and Forecast to 2030 (US$ Million)
Table 27. Rest of Middle East & Africa Newborn Screening Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 28. Recent Organic Growth Strategies in Newborn Screening Market
Table 29. Recent Inorganic Growth Strategies in the Newborn Screening Market
Table 30. Glossary of Terms, Newborn Screening Market
LIST OF FIGURES
Figure 1. Middle East & Africa Newborn Screening Market Segmentation, By Country
Figure 2. Newborn Screening Market – Key Industry Dynamics
Figure 3. Impact Analysis of Drivers and Restraints
Figure 4. Middle East & Africa Newborn Screening Market Revenue (US$ Mn), 2022 – 2030
Figure 5. Middle East & Africa Newborn Screening Market Revenue Share, by Product Type, 2022 & 2030 (%)
Figure 6. Reagents and Assay Kits: Middle East & Africa Newborn Screening Market – Revenue and Forecast to 2030 (US$ Million)
Figure 7. Instruments: Middle East & Africa Newborn Screening Market – Revenue and Forecast to 2030 (US$ Million)
Figure 8. Middle East & Africa Newborn Screening Market Revenue Share, by Technology 2022 & 2030 (%)
Figure 9. Tandem Mass Spectrometry (TMS): Middle East & Africa Newborn Screening Market – Revenue and Forecast to 2030 (US$ Million)
Figure 10. Molecular Assays: Middle East & Africa Newborn Screening Market – Revenue and Forecast to 2030 (US$ Million)
Figure 11. Immunoassays and Enzymatic Assays: Middle East & Africa Newborn Screening Market – Revenue and Forecast to 2030 (US$ Million)
Figure 12. Pulse Oximetry Screening Technology: Middle East & Africa Newborn Screening Market – Revenue and Forecast to 2030 (US$ Million)
Figure 13. Other Technologies: Middle East & Africa Newborn Screening Market – Revenue and Forecast to 2030 (US$ Million)
Figure 14. Middle East & Africa Newborn Screening Market Revenue Share, by Test Type 2022 & 2030 (%)
Figure 15. Dry Blood Spot Test: Middle East & Africa Newborn Screening Market – Revenue and Forecast to 2030 (US$ Million)
Figure 16. Hearing Screen Test: Middle East & Africa Newborn Screening Market – Revenue and Forecast to 2030 (US$ Million)
Figure 17. Critical Congenital Heart Diseases (CCHD) Test: Middle East & Africa Newborn Screening Market – Revenue and Forecast to 2030 (US$ Million)
Figure 18. Other Test Types: Middle East & Africa Newborn Screening Market – Revenue and Forecast to 2030 (US$ Million)
Figure 19. Middle East & Africa Newborn Screening Market Revenue Share, by End User, 2022 & 2030 (%)
Figure 20. Hospitals and Clinics: Middle East & Africa Newborn Screening Market – Revenue and Forecast to 2030 (US$ Million)
Figure 21. Diagnostic Laboratories: Middle East & Africa Newborn Screening Market – Revenue and Forecast to 2030 (US$ Million)
Figure 22. Middle East & Africa Newborn Screening Market, by Key Country – Revenue, 2022 (US$ Million)
Figure 23. Middle East & Africa Newborn Screening Market, By Key Countries, 2022 and 2030 (%)
Figure 24. Saudi Arabia Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
Figure 25. UAE Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
Figure 26. South Africa Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
Figure 27. Rest of Middle East & Africa Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
Figure 28. Growth Strategies in Newborn Screening Market
The List of Companies – Middle East & Africa Newborn Screening Market
1. Bio-Rad Laboratories Inc
2. Masimo Corp
3. Medtronic Plc
4. PerkinElmer Inc
5. Waters Corp
You must be logged in to post a review.
Reviews
There are no reviews yet.